Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors.
Toyodome A, Mawatari S, Eguchi H, Takeda M, Kumagai K, Taniyama O, Ijuin S, Sakae H, Tabu K, Oda K, Ikeda M, Ido A
Sci Rep. 2024 Jul 16;14(1):16363. DOI: 10.1038/s41598-024-67169-5. PMID: 39013947
Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus.
Li J, Takeda M, Imahatakenaka M, Ikeda M
J Med Virol. 2024 Jan;96(1):e29372. DOI: 10.1002/jmv.29372. PMID: 38235544